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Abstract
Background
Magnetic Resonance Imaging (MRI) relies on optimal scanning parameters to achieve maxi-
mal signal-to-noise ratio (SNR) and high contrast-to-noise ratio (CNR) between tissues
resulting in high quality images. The optimization of such parameters is often laborious, time
consuming, and user-dependent, making harmonization of imaging parameters a difficult
task. In this report, we aim to develop and validate a computer simulation technique that can
reliably provide “optimal in vivo scanning parameters” ready to be used for in vivo evaluation
of disease models.
Methods
A glioblastoma murine model was investigated using several MRI imaging methods. Such
MRI methods underwent a simulated and an in vivo scanning parameter optimization in pre-
and post-contrast conditions that involved the investigation of tumor, brain parenchyma and
cerebrospinal fluid (CSF) CNR values in addition to the time relaxation values of the related
tissues. The CNR tissues information were analyzed and the derived scanning parameters
compared in order to validate the simulated methodology as a reliable technique for “optimal
in vivo scanning parameters” estimation.
Results
The CNRs and the related scanning parameters were better correlated when spin-echo-
based sequences were used rather than the gradient-echo-based sequences due to aug-
mented inhomogeneity artifacts affecting the latter methods. “Optimal in vivo scanning
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parameters” were generated successfully by the simulations after initial scanning parameter
adjustments that conformed to some of the parameters derived from the in vivo experiment.
Conclusion
Scanning parameter optimization using the computer simulation was shown to be a valid
surrogate to the in vivo approach in a glioblastoma murine model yielding in a better delinea-
tion and differentiation of the tumor from the contralateral hemisphere. In addition to drasti-
cally reducing the time invested in choosing optimal scanning parameters when compared
to an in vivo approach, this simulation program could also be used to harmonize MRI acqui-
sition parameters across scanners from different vendors.
Introduction
A common approach to brain tumor imaging includes anatomical and physiological MRI in
order to achieve volumetric and functional evaluations of the disease [1–3]. The anatomical
portion of the investigation encompasses the use of pre- and post-contrast MRI spin- and gra-
dient-echo-based sequences. Among these, the Fast-Spin-Echo (FSE) and the Fluid Attenuated
Inversion Recovery (FLAIR) as well as the standard Gradient-Echo (GRE) and the Magnetiza-
tion-Prepared Rapid Gradient-Echo (MP-RAGE) are the preferred MRI methods. These
sequences generate high quality images in a limited scan time and provide precise and accurate
volumetric measurement of the tissue of interest after appropriate analysis.
Once a tumor is accurately detected and delineated, the MR images can be used to add diag-
nostic information by examining their T1 and T2 properties. For instance, the signal charac-
teristics of the lesion may provide clues about its underlying composition that are relevant for
its characterization [4]. T1 hyperintensity usually denotes fat, subacute hemorrhage, protein-
rich fluid, slow vascular flow or contrast enhancement, while T1 hypointensity may represent
cerebrospinal fluid (CSF) or a relative increase in tissue water in tumor or areas of edema. T2
hyperintensity associates with relative tissue increase in water such as in edema, tumor cells,
inflammation or infection, while T2 hypointensity identifies paramagnetic substances such as
deoxyhemoglobin, hemosiderin and iron, calcification and protein-rich fluid. Administration
of contrast agent is usually utilized for perfusion and permeability assessments on dynamic
scans in addition to highlighting permeable sites on a “static image” acquired several minute
after injection. Investigating and optimizing all the MRI aspects underlined in such studies,
often necessitates a pre-clinical investigation.
A pre-clinical study of murine models for human cancer requires the identification of
mice-bearing tumors and the quantitation of tumor size for stratification, measurements of
tumor growth rate, and assessment of treatment response. The optimization of MRI anatomi-
cal sequences is often the first step in order to maximize the information available [5]. A
murine glioblastoma tumor model was chosen in this study to represent one of the most genet-
ically heterogeneous, resistant and lethal of all human cancers [6]. Several studies in the past
have approached the glioblastoma murine model utilizing various in vivo imaging methods [7,
8] with MRI as the methodology of choice whenever a detailed investigation of tumor growth
is necessary in a non-invasive manner.
Standardization of MRI scanning parameters is the key for consistent and comparable
image quality between examinations in longitudinal and multicenter studies. Although a
theoretical approach describing the magnetization evolution during an acquisition is well
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established, both clinical and pre-clinical studies use scanning parameters that are mostly
designed to achieve high quality, but often differ between institutions. In an effort to harmo-
nize the choice of MRI scanning parameters for in vivo examination of a glioblastoma murine
model using a 7T scanner, this study aimed at generating reliable computer simulation pro-
grams that automatically produce “optimal in vivo scanning parameters” as to replace the time-
consuming and often inconsistent MRI in vivo parameters optimization approach, while pro-
viding a series of guidelines which can be used reproducibly in longitudinal studies and across
centers equipped with MRI from different vendors. We investigated several MRI sequences
such as FSE, FLAIR, GRE and 3D MP-RAGE in the context of pre- and post- administration
of the Gd-DTPA contrast agent, using both an in vivo and simulated MRI of the murine
tumor model. The results were then compared and optimal parameters were selected. Such
optimal scanning parameters aimed at providing better delineation and differentiation
between tissues under study than non-optimized parameters, therefore improving characteri-
zation and analysis of the tissue of interest.
The development of a simulated approach and its validation to an in vivo scenario is not a
trivial task. In vivo conditions are much more complex than the simulated ones due to resident
inhomogeneity and biological conditions. Herein, we demonstrate that achieving “optimal in
vivo scanning parameters” by simulation is possible and deliverable with the minimal contribu-
tion of a set of information achieved in vivo that are targeted to optimize some of the initial
simulated scanning parameters.
Materials and methods
MRI theory
Theoretical calculation for spin- and gradient-echo-based sequences assume that all radiofre-
quency (RF) pulses give exactly the desired flip angles, that any effects due to stimulated echoes
are not considered, that RF pulses act instantaneously and have the same effect across the
whole slice thickness. In addition, it is assumed that all transverse magnetization either decays
or is spoiled before each TR (repetition time). The following theory equations are based on a
standard Cartesian acquisition and k-space gridding.
Spin-echo-based sequences
Spin-echo-based acquisitions are used widely in pre-clinical and clinical MRI because they
provide a variety of image contrasts that highlights pathology and are resistant to image
artifacts from RF and static field inhomogeneity. They can be engaged both as T1- and
T2-weighted sequences or to suppress a specific signal such as that of the CSF. The sequences
studied in this work are the Fast-Spin-Echo (FSE) and the Fluid Attenuated Inversion Recov-
ery (FLAIR).
Fast-Spin-Echo (FSE). Fast-Spin-Echo (FSE) or Turbo-Spin-echo (TSE) pulse sequences
are optimized derivatives of the Rapid Acquisition with Relaxation Enhancement (RARE)
technique [9]. The primary difference between the more standard method and the FSE lays in
the use of a multi-echo approach. FSE combines the desirable properties of spin-echo-based
acquisitions with the speed advantage of collecting multiple lines of phase-encoding data fol-
lowing each 90˚ RF excitation. This method is used for a broad spectrum of MRI applications
going from anatomical organ or tumor volume estimation [10] to diffusion imaging [11, 12].
The method can be employed either as a T1- or proton density or a T2-weighted sequence by
varying the TR and TE parameters. Short TR (<1000ms) and TEeff (<40ms) were engaged to
investigate T1-weighted images while long TR (>4000ms) and TEeff (>40ms) were used for
T2-weighted images [13].
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The signal intensity general equation presented for a multiple-spin-echo sequence for the
nth readout pulse can be reported as follow:
Sn  Mn  exp  
TEn
T2
 
; ð1Þ
where “n” identifies the nth read out pulse, Mn the nth magnetization, TEn is nth echo where T2
is the transverse relaxation time. The magnetization can be expanded as Conturo et al. [14]
described after a first-order approximation assuming that the echo spacing between successive
echoes (ESP) is<< T1:
Mn M0 1   exp  
TDn
T1
  
; ð2Þ
where TD nth is the time interval between the last echo train and the TR period, which is given
by:
TDn ¼ TR   ETL  ESP; ð3Þ
the echo train length (ETL) also determines the speed of the FSE sequence. Note that the signal
from each echo is also a function of the proton density and the instrumental gain that are
intrinsic variables usually not reported in the general signal equation.
Fluid attenuated inversion recovery (FLAIR). T2-weighted fluid attenuated inversion
recovery (FLAIR) became a standard and robust approach in clinical magnetic fields strengths
for neuroimaging investigation [15, 16]. Therefore the use of this sequence in pre-clinical stud-
ies could be especially useful in translational and co-clinical trial designs [17].
FLAIR pulse sequence relies on the application of a single 180˚ inversion pulse to null the
signal from tissues such as the CSF. FLAIR uses a FSE readout where the signal from each echo
is a function of the relaxation time TI, T1, T2 decay, as well as the number of ETL, the TR and
ESP.
Mn M0 1   2exp  
TI
T1
 
þ exp  
TR   ðETL  ESPÞ
T1
  
; ð4Þ
The equation and its approximations are reported in more details in the manuscript by Meara
S. J. P. and Barker G. J. manuscript [10].
Gradient-echo-based sequences
Gradient-echo techniques have numerous applications both clinically and pre-clinically, such
as high resolution anatomic imaging, contrast-enhanced imaging, angiography and perfusion
[12, 18–20]. In this study, we simulated a standard gradient-echo technique and a 3D
MP-RAGE that are commonly used in the clinic and can be accurately translated to a pre-clini-
cal environment.
Gradient-echo (GRE). Gradient-echo sequence can be used as a T2- or T1-weighted,
rarely as proton density PD sequence by modification of the TR, TE and flip angle parameters.
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The signal intensity general equation presented for a gradient-echo-based sequence for the
nth readout pulse can be reported as follow:
Sn  Mnsin yð Þ  exp  
TEn
T
2
 
; ð5Þ
Mn ¼
1   expð  TRT1Þ
1   cosðyÞ  expð  TRT1Þ
; ð6Þ
where TR is the repetition time between two consecutive RF pulses and θ is the flip angle. Note
that the signal from each echo is also a function of the proton density and the instrumental
gain that are intrinsic variables usually not reported in the general signal equation.
Magnetization-prepared rapid gradient-echo (MP-RAGE). First introduced by Muger
and Brookeman [21], the sequence combines the power of magnetization-prepared imaging
and rapid 3D gradient echo acquisition techniques to provide excellent T1 tissue contrasts and
high spatial resolution images using a short scanning time. Also, MP-RAGE three-dimensional
Fourier transform gradient echo acquisition method offers easy reconstruction of any plane
and three-dimensional surface contour rendering with cut away post-processing [22].
Although mainly utilized in brain imaging [23], the method can be applied to a vast number of
applications.
MP-RAGE signal equation is a function of the time interval between the inversion recovery
pulse (TI), T1 and T2 decay, as well as flip angle (θ), TR and TE. Signal intensity from the nth
read-out pulse is given by [22, 24]:
Mn ¼ M0
ð1   dÞ  ð1   mn  1Þ
1   m
þ mn  1  ð1   gÞ   g  mi  1 
Meq
M0
 
; ð7Þ
where:
d ¼ exp  
ESP
T1
 
; ð8Þ
m ¼ d  cosðyÞ; ð9Þ
g ¼ exp  
TI
T1
 
; ð10Þ
φ ¼ exp  
TD
T1
 
; ð11Þ
TR ¼ TI þ N  ESPþ TD; ð12Þ
where N is the total number of readout RF pulses and Meq is the steady state magnetization
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after several TRs.
Meq
M0
¼
1   φþ φcosðyÞð1  dÞð1  m
N  1Þ
1  m
þ φ  cosðyÞ  mN  1   r  cosNðyÞ
1þ r  cosNðyÞ
; ð13Þ
r ¼ exp  
TR
T1
 
; ð14Þ
Contrast to noise ratio (CNR)
The contrast to noise ratio (CNR) between two regions of an image, is defined as the difference
in SNR of those regions:
CNR ¼ SNR1   SNR2; ð15Þ
the simulated SNR was calculated as:
SNR 
FOVx  FOVy  Dz  Fsequence
ffiffiffiffiffiffiffiffiffi
NSA
p
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
BW  NFE  NPE
p ; ð16Þ
where FOV is the field of view, Δz is the slice thickness, Fsequence is the signal intensity equa-
tion, NSA the number of averages, BW is the total receiver bandwidth and NFE and NPE are
the number of frequency encoding and phase encoding, respectively.
Note that the simulated CNR will be only proportional to the contrast to noise obtained in
an in vivo experiment due to the simplified nature of the equation that does not consider the
electronic impedance of the transmitter/receiver coil or the electric noise produced by our
hardware.
Experiments
Validating the simulation approach versus the in vivo approach. The validation of our
MRI simulation approach versus the in vivo approach is based on the study of the magnetiza-
tion effects that each scanning parameter produces when dynamically changed. Only by
understanding such effects, will the computer model be able to accurately provide those opti-
mal scanning parameters which, when used in an in vivo experiment, culminate in maximum
CNR between tissues of interest.
The in vivo and simulated approaches are introduced below.
The in vivo approach. The in vivo approach illustrated on the left side of Fig 1 shows the
main steps required to achieve the “optimal in vivo scanning parameters”. The method involves
a lengthy series of MRI acquisitions as a first step where parameters such as TR, ESP, ETL, flip
angle (FA), TI (inversion time) are changed. CNR data analysis between tissues of interest are
then performed, maximum CNR values calculated and the related “optimal in vivo scanning
parameters” found. Of note, in practical terms the in vivo approach cannot be entirely fulfilled
because the total scan time is typically constrained to a few hours depending on the diseased
animal model in use. However, restricting the scanning conditions to a limited number of
parameters, still allows the “optimal in vivo scanning parameters” to be accurately defined.
The in vivo approach with limited parameters was engaged in FSE, GRE and MP-RAGE for
T1- and T2-weighted acquisitions both in pre- and post-contrast conditions. FLAIR was run
only as a T2-weighted pre-contrast.
The simulation approach. Our MRI computer simulation (C++ code) computed all the
equations presented in the Theory section to determine the SNR of brain parenchyma, CSF
and tumor tissues and the related CNR. The computer simulation varied, in a dynamic fashion
Validating MRI simulation versus in-vivo for optimal scanning parameters
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through a numerical calculation, parameters such as ESP, ETL, TR, NSA, FA, TI and scan time
in order to study the effects of the latters on the magnetization. The range, within which the
parameters were studied, was similar between in vivo and simulation, in fact, the latter mir-
rored all the in vivo experiments. In a second step, the simulation computed the SNRs of the
tissues under study and produced a CNR analysis to estimate the maximum values. Such val-
ues exposed the “optimal computed scanning parameters”. In order to associate the latter com-
puted parameters to the “optimal in vivo scanning parameters”, a scanning parameter
comparison analysis was performed between optimal in vivo and computed scanning
Fig 1. In vivo and simulation approaches diagrams representation. The IN VIVO approach uses a long series of imaging experiments to investigate how the change in
MRI scanning parameter affects the SNR of tissues. Once completed, the CNR between selected tissues is analyzed (CNR data analysis) and “optimal in vivo scanning
parameters” are identified. Conversely, the SIMULATION approach uses a numerical calculation to estimate the magnetization effects on tissues. The simulation uses
T1, T2 and T2 values of such tissues, and, in addition, dynamically varies the scanning parameters as input variables. The CNR between selected tissues are then
computed and analyzed by the simulation program. “Optimal computed scanning parameters” are therefore provided to the user. A verification of the computed
scanning parameters versus the in vivo scanning parameters is necessary at this stage (scanning parameter compared analysis). If the outcome is positive (YES),
computed and in vivo scanning parameters are similar and the parameter will therefore be considered as an “optimal in vivo scanning parameter”. In a negative case
(NO), those parameters that differ from the in vivo case, will be reinserted in the simulation emulating the in vivo value and the simulation rerun. Such diagrams are
valid in both pre- and post-contrast conditions. Note that the in vivo method is much more time consuming than the simulated approach due to the lengthy parameters’
acquisition experiments that will be mostly replaced by a numerical calculation when using the simulation.
https://doi.org/10.1371/journal.pone.0200611.g001
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parameters. In those cases where the comparison analysis failed, the initial simulated condi-
tions (input variables) had to be adjusted to the in vivo optimum value and the simulation
repeated (right side of Fig 1).
Cell line. The luciferase-transduced murine glioblastoma cell line GL261-luc2 was pur-
chased (Perkin-Elmer) in 2014 and chosen for its syngeneic ability in the murine model. Cells
were cultured and expanded in DMEM supplied with 10% FCS and selected under 100μg/mL
G418. Cells were grown on culture flasks housed in an incubator maintained at 5% CO2 set at
37˚.
Murine model. All procedures and imaging protocols for this study were approved and
performed in accordance with Dana-Farber Cancer Institute’s Institutional Animal Care and
Use Committee (IACUC). For the intercranial injection of the GL261-luc2 cells, eight 6–-
10-week old female B6(Cg)-Tyrc-2J/J mice (The Jackson Laboratory, Bar Harbor, ME) were
anesthetized for the duration of the procedure using 2% isoflurane mixed with medical air,
and placed on a stereotactic frame. The skull of the mouse was exposed through a small skin
incision, and a burr hole was made using a 25G needle at 2.0 mm lateral of the bregma. The
GL261-luc2 cells (1 x 105 cells in 2μL PBS) were then loaded into a 33G Hamilton syringe and
injected 2 mm below the cortical surface of the brain over a one-minute time span.
After suturing the scalp, mice were given a topical anesthetic (Bupivacaine) and an intraper-
itoneally injected (IP) analgesic (0.05mg/kg buprenorphine). They were then returned to their
cages, placed on a warming pad and visually monitored until full recovery. Mice were checked
daily for any signs of distress, which included weight loss, dehydration, neurological symptoms
such as tremors, seizures, ataxia, and any skull deformation due to advanced tumor growth.
Dependent upon the severity of any observed symptoms, body condition scoring and/or
tumor size (>500 mm3 calculated from the analysis of MR images), the mice were euthanized
by CO2 asphyxiation in accordance with DFCI IACUC protocols. No animals died due to the
experimental procedures. The median survival of the tumor-bearing mice without any thera-
peutic intervention was approximately 28 days post-tumor cell injection.
MRI imaging. MRI in vivo studies were performed on 8 glioblastoma-bearing mice at
about 20 days post-cell injection using a 7T/30 cm USR horizontal bore Superconducting
Magnet System 300.3 MHz (Bruker BioSpin MRI, Ettlingen, Germany BioSpec). The scanner
was equipped with the B-GA12S2 gradient and integrated with up to 2nd order shim system,
which provides a maximum gradient amplitude of 440 mT/m and slew rate of 3440 T/m/s.
The Bruker-made transmit/receiver 23 mm ID birdcage volume radiofrequency (RF) coil was
used for brain images.
Anesthesia was maintained at a flow rate of 2 l/min through inhalation of a mixture of 1.5%
isoflurane and O2. Body temperature was maintained at 37˚ using a forced warm air fan sys-
tem. Animal respiration and temperature were monitored and regulated by the SAII (Stony
Brook, NY) monitoring and gating system model 1025T. The mice were injected intraperito-
neally (IP) with 0.5 mmol/kg of gadopentetate dimeglumine Gd-DTPA (Magnevist, Bayer,
Germany). Pre-contrast acquisitions were obtained in addition to post-contrast images. Post-
contrast imaging started at 30 min post-injection.
Bruker Paravision 6.0.1 was used for MRI data acquisition. The geometry and pixel size
were maintained constant throughout all the sequences. To limit inhomogeneity correction
typical of regridding techniques, in addition to minimizing acquisition scheme artifacts [25,
26], a Cartesian acquisition scheme with no undersampling was preferred to non-Cartesian.
For the 2D brain images, a FOV = 20x20 mm2, matrix size = 192x192x29 and slice thick-
ness = 0.5 mm were used, while a FOV = 20x20x20 mm3 and a matrix size = 128x128x128
were used for the 3D acquisition. The sequences used in this study were FSE and FLAIR as
spin-echo based sequences and GRE and MP-RAGE as gradient-echo based sequences.
Validating MRI simulation versus in-vivo for optimal scanning parameters
PLOS ONE | https://doi.org/10.1371/journal.pone.0200611 July 23, 2018 8 / 22
The scanning parameters used for the parameters’ optimization of the in vivo portion of the
study were chosen within standard ranges (typically utilized in preclinical mice experiments)
in order to render the study more effective and less time-consuming. Details of such parame-
ters are discussed in the following sections.
T1, T2 and T2. To estimate T1, T2 and T2 values of brain parenchyma, CSF and tumor
areas, a spin-echo sequence with variable TR and TE (RAREVTR) was used for simultaneous
T1 and T2 mapping. Scanning parameters were: 7 T1 experiments TR = 7000, 5500, 3000,
1500, 800, 400, 278 ms, 5 T2 experiments ESP = 8.5, 25.5, 42.5, 59.5, 76.5 ms, NSA = 1, FA =
90/180, ETL = 2, BW = 50 MHz, matrix = 128x128x3, FOV = 20x20x3 mm3, scan time 15
min. T2 mapping was achieved with the use of a multi-echo GRE sequence as follows: TR =
1000 ms NSA = 2, TE = 2.4 (BW = 75 MHz), echoes = 15, ESP = 4ms, FA = 30; matrix =
128x128x3, FOV = 20x20x3 mm3, scan time = 4 min 16 sec.
The sequences were run on all 8 glioblastoma brain tumor-bearing mice. Notably, attain-
ment of T1 and T2 spin echo contrast between white and gray matter is generally more chal-
lenging at high B0 rather than low magnetic fields, thus implying a convergence in relaxation
values between such tissues at high fields [27]. For this reason, the relaxation times achieved in
the contralateral hemisphere were, most probably, a combination of the two relaxation tissues.
Fast-Spin-Echo (FSE). The glioblastoma brain tumor murine model was investigated
with a Fast-Spin-Echo in both T2 and T1-weighted pre- and post-contrast. In T2-weighted
(FSET2) examinations, the first step was to evaluate the magnetization effects while varying
ESP and maintaining the other parameters constant. The following initial parameters were
used: TR = 6000 ms, NSA = 1, ETL = 13, ESP changed from 5.4 to 6, 7.4, 9.4, 11.4, 13.4, 15.4,
17.4 ms with consequent BW variation (from 100 to 13.5 MHz). After CNR data analysis, the
best ESP for in vivo studies was determined. In a second step, the experiment was repeated
maintaining ESP to the founded value but varying ETL from 10 to 20 (increment of 1). The
last step was to change the TR from 4000 to 10000 ms in 1000 ms increments while engaging
the maximum number of averages (NSA) without exceeding the 5-minute scanning limit.
These steps determined the “optimal in vivo scanning parameters”.
The Fast-Spin-Echo T1-weighted (FSET1) sequence was performed following similar steps
and scan time restrictions of 5-minute acquisitions. Images parameters were initially set to
TR = 700 ms, NSA = 3, ETL = 1 and ESP varied from 5.4 to 6, 7.4, 9.4, 11.4, 13.4 ms (BW from
100 to 20 MHz) in the first step. Having found the optimal ESP, ETL was then changed from 1
to 5. Maintaining ESP and ETL at their best value, TR was then changed from 500 (minimum
TR) to 800 ms to investigate TR contribution on the SNR of normal and tumor tissues, while
using the maximum number of NSA at the same time without exceeding the 5-minute scan-
ning limit. “Optimal in vivo scanning parameters” were then determined.
Of note, FSET2 ETL values lower than 10 were not utilized because of scan time limits,
while using ETL higher than 20 would have encountered significant SNR drops, therefore
deteriorating image quality. Also, the recovery time in the FSET2 method did not fall below
4000 ms in order to maintain strong T2-weighted effects. Similarly, in the FSET1 method, TR
did not overcome 1000 ms to maintain T1-weighted effects.
Fluid attenuated inversion recovery (FLAIR). In the FLAIR pre-contrast method, the
following initial parameters were used: TR = 8000 ms, ESP = 7.4 (BW = 50 MHz), ETL = 1,
NSA = 1 and TI varied from 1100 to 3100 ms (200 ms increment). Such experiment meant to
assess the best TI value for the in vivo applications. In a second step, TI was maintained at the
optimal in vivo value while TR ranged from 6000 to 25000 ms (non-constant increments). In
this test, the scanning time of each experiment was limited to 10 minutes, and as a conse-
quence NSA was maintained equal to 1, while the ETL number was limited to the minimum
value (TR = 6000 ms ETL = 2; TR = 7000 to 9000 ETL = 3; TR = 10000 to 11000 ms ETL = 4;
Validating MRI simulation versus in-vivo for optimal scanning parameters
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TR = 15000 ms ETL = 5; TR = 20000 ms ETL = 7; TR = 25000 ms ETL = 9). This step provided
optimal TR and ETL to complete the “optimal in vivo scanning parameters”.
Gradient-echo (GRE). The GRE sequence was used as a T1-weighted pre- and post-con-
trast method on the tumor-bearing mice. As a pre-contrast sequence, it offered low CNR
between the brain parenchyma and tumor tissues while producing good contrast between soft
tissue, blood and CSF. As a first step, GRE parameters were set to TR = 275 ms (minTR),
TE = 3.5 (BW = 50 MHz), NSA = 3, variable FA (from 10 to 90 degrees) in order to investigate
FA effects on the magnetization. In a second step, the FA was maintained to the optimal value
and TR varied from 275 to 350, 500, 700 and 1000 ms combined with the maximum number
of NSA without exceeding the 5-minute scan time limit. “Optimal in vivo scanning parameters”
were then defined.
Magnetization-prepared rapid gradient-echo (MP-RAGE). MP-RAGE examination
was engaged as a T1-weighted pre- and post-contrast agent method. To assess the optimal TI
parameters for the in vivo study of the glioblastoma murine model, the sequence parameters
were set to: TR = 1983 (minTR), TE = 2.3 ms (minTE) (BW = 75 MHz), segment = 1, NSA = 1,
FA = 10˚, and TI varied between 500 and 3500 ms (500 ms increment). In a second step, while
maintaining the TI constant at the optimal in vivo value, the FA was changed from 10˚ to 90˚
and NSA was maximized in a scan time limit of 5 minutes. The analysis of CNR values pro-
vided the “optimal in vivo scanning parameters”.
Data analysis
T1, T2 and T2 values were calculated by employing the Image Sequence Analysis (ISA) Tool
provided by Bruker Paravision which uses dedicated mathematical functions to best fit the
data. The same region of interest (ROI) were maintained throughout the dataset for the analy-
sis of brain parenchyma, CSF and tumor tissues. Tumor ROIs were placed in 3 consecutive
slices, typically in the middle of the tumor, to achieve a T1, T2 and T2 value representative of
the entire tumor volume. T1, T2 and T2 mean values ± standard deviations (SD) were calcu-
lated for individual mice as well as for the entire cohort by averaging over the three slices. The
Wilcoxon signed rank test was used to compare T1, T2, and T2 values averaged over three
slices from brain parenchyma, CSF, and tumor tissues before and after contrast administra-
tion. To assess the variability in T1, T2 and T2 values in brain parenchyma, CSF, and tumor
tissues, a repeated measures Analysis of Variance (ANOVA) model was fit for each T1, T2,
and T2 variable. Mice were included as a fixed effect to evaluate the differences in values
between the mice, and a random effect with slice measurements nested within each mouse was
included to evaluate the variability within each mouse.
The SNR values from the in vivo data were analyzed with the ImageJ software (National
Institutes of Health, Bethesda, MD) by placing ROIs in the contralateral hemisphere, in CSF
and in tumor areas. The analysis was typically repeated in 3 consecutive slices and a CNR
mean value ± SD in addition to the coefficients of variation were also derived. A CNR data
analysis specific to each scanning parameter was then performed and the highest CNR values
assessed. In order for a scanning parameter to be evaluated as an “optimal in vivo scanning
parameter”, two conditions had to be satisfied: 1) the image had to be free of artifacts derived
either from off resonance effect, motion, chemical shift or blurring effects, therefore assuring
good image quality (image quality analysis test); 2) the CNR had to be found maximized. CNR
mean values ± SD and the related coefficients of variation were calculated for individual mice
as well as for the entire cohort.
In the simulation case, the data analysis of the computed CNR values was integrated in the
computer program. Due to the absence of an image quality analysis test, the highest computed
Validating MRI simulation versus in-vivo for optimal scanning parameters
PLOS ONE | https://doi.org/10.1371/journal.pone.0200611 July 23, 2018 10 / 22
CNR values always identified the “optimal computed scanning parameters”. Such scanning
parameters were then compared to the optimal scanning parameters derived by the in vivo
study as part of the “scanning parameter comparison analysis”. When the simulated matched
the in vivo parameters, the “optimal computed scanning parameters” could be considered as
“optimal in vivo scanning parameters” thus validating the simulation.
To assess the similarity between in-vivo and simulated CNR data, we computed the correla-
tion of CNR data from the two different methods using Kendall’s tau coefficient (τ). The coef-
ficient ranges from -1 to 1, with values closer to -1 or 1 indicating higher negative (-1) or
positive (1) correlation.
Results
T1, T2 and T2 values
Table 1 reports the mean value ± SD for T1, T2 and T2 values at 7T for brain parenchyma,
CSF and tumor tissues in the 8 tumor-bearing mice. We find that T1, T2, and T2 values did
not change significantly from pre- to post-contrast acquisitions in non-diseased brain paren-
chyma and CSF. In tumors tissues, while T2 did not change significantly from pre- to post-
contrast acquisitions, a significant decrease was observed in T1, as expected, and T2 values in
tumors from pre- to post-contrast acquisitions (p-value = 0.004 and 0.022, respectively). The
variability within mice was generally smaller than the variability between mice (S1 Table). The
latter variability between mice resulted in all cases smaller or equal than 10% of the corre-
sponded mean value. The similar T1 values found before and after contrast administration in
both CSF and non-diseased brain parenchyma could be explained by the integrity of the blood
brain barrier in healthy brain tissues, in addition to the rapid washout of the contrast agent.
Spin-echo based sequences
The results for the procedures of parameter optimization (pre- and post-contrast conditions)
are presented in Fig 2 for FSET1 and in S1 Fig for all the spin-echo based cases. The reported
graphs are representative of a single mouse in vivo experiment, but are representative of the
entire animal cohort. Mean CNR values for individual animals were associated with a coeffi-
cient of variation typically smaller than 10%. A similar outcome was also found when calculat-
ing the coefficient of variation of the entire cohort thus supporting the accuracy of our
measurements and the repeatability of the mouse model. Error bars are not included in the
graphs.
It should to be noted that the magnitude of the computed and in vivo single CNR values dif-
fer significantly from each other primarily due to the complexity in simulating a real MRI
experiment. In fact, the scanner hardware on one end, and the complex biological tissues com-
position on the other, are primary factors for such magnitude discrepancies. In the case of a
MRI scanner, the electronic and hardware components deeply affect both acquisition and
Table 1. T1, T2 and T2 values (mean ± SD in the 8 tumor-bearing mice) for brain parenchyma, CSF and tumor tissues of a glioblastoma murine model under pre-
contrast and post-contrast conditions.
Pre-contrast Post-contrast
(30 minutes)
Brain parenchyma CSF Tumor Brain parenchyma CSF Tumor
T1±SD (ms) 2565.13±161.81 3553.53±125.49 3221.08±118.61 2491.88±76.09 3477.46±137.74 1032.96±49.19
T2±SD (ms) 46.04±1.02 165.75±16.20 68.67±2.15 47.38±2.07 154.08±7.06 63.79±5.47
T2±SD (ms) 27.46±1.60 91.91±25.20 37.71±1.86 26.29±0.86 82.88±15.51 34.33±0.99
https://doi.org/10.1371/journal.pone.0200611.t001
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Fig 2. Fast-Spin-Echo CNR data and scanning parameters comparison analysis. Fast-spin-echo T1-weighted (FSET1) brain parenchyma-tumor mean CNR graphical
representation. In pre-contrast conditions: graphs A1,3,5) and A2,4,6) report respectively in vivo and simulated CNR FSET1 data when changing ESP, ETL, TR and NSA
(the scan time was limited to 5 minutes). In post-contrast conditions: graphs B1,3) and B2,4) reported respectively in vivo and simulated CNR FSET1 data when changing
ESP, TR and NSA (the scan time was limited to 5 minutes). Black arrows point at selected parameters that typically coincide with the highest CNR providing the
“optimal in vivo scanning parameters” for the in vivo method, and the “optimal computed scanning parameters” with the simulated approach. The latter parameters are
Validating MRI simulation versus in-vivo for optimal scanning parameters
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amplification of the MRI signal making it unique to every machine. The software used for the
in vivo data analysis can also represent a contributing factor to the final magnitude. Black
arrows reported in Fig 2 and S1 Fig identified the optimal parameters found for the in vivo
and simulated approach.
A full view of the “optimal in vivo scanning parameters” spin-echo base sequences is
reported in Table 2.
Fast-Spin-Echo (FSE). In-vivo and simulated CNR data were highly correlated for most
of the parameters analyzed as in Fig 2 and S1 Fig (Kendall’s tau coefficient τ for FSET1 is:
0.36 A1—A2; 1 A3 –A4; 0.55 A5 –A6; 1 B1—B2; 1 B3 –B4); 0.93 S1A1 –S1A2; 0.55 S1A3 –S1A4;
0.43 S1A5 –S1A6). This was found in pre- and post-contrast conditions for both T2- and
T1-weighted dataset, confirming that the FSE simulation is a reliable method in reproducing
real case scenarios and thus achieves optimal scanning parameters qualification.
Fig 2A1 and 2B1 highlighted the optimal ESP in vivo value after assessing CNR in combina-
tion with the related image quality as described in the “Data Analysis” section. It was found
that when using echo spacing larger than 7.4 ms (50MHz) in the T1-weighted methods, and
similarly in the T2-weighted methods, chemical shift and distortion artifacts were introduced
resulting in significantly diminished image quality. Hence, using 7.4 ms resulted in a good
compromise between in vivo maximal CNR and artifacts’ minimization. On the other hand,
the simulation (Fig 2A2, 2B2) selected the best ESP simply based on the CNR magnitude. The
in vivo and simulated ESP values were different, therefore failing the scanning parameter com-
parison analysis. ESP was then re-inserted in the computer program and maintained constant
at the optimal in vivo value. When changing either ETL (Fig 2A3) or TR in addition to NSA
(Fig 2A5 and 2B3), the simulation (Fig 2A4, 2A6 and 2B4) computed well the magnetization
effects observed in the in vivo experiments, resulting in a successful scanning parameter com-
parison analysis.
Fluid attenuated inversion recovery (FLAIR). S1C1 and S1C2 Fig reported a similar data
trend when varying TI (high Kendall’s tau coefficient, 0.75). Both in vivo and simulation
compared by the “Scanning parameters comparison analysis” and the outcome reported as successful (YES) or failing (NO). Note that although the graphs are related to
a single mouse dataset, they are a good representation of the entire animal cohort.
https://doi.org/10.1371/journal.pone.0200611.g002
Table 2. Pre- and post-contrast “optimal in-vivo scanning parameters” for spin-echo and gradient-echo-based sequences in a glioblastoma murine model.
Pre-contrast Post-contrast
Spin-Echo based Gradient-Echo based Spin-Echo based Gradient-Echo based
FSET2 FSET1 FLAIRT2 GRET1 MP-RAGET1 FSET1 GRET1 MP-RAGET1
TR (ms) 7000 500 9000 350 1983 500 275 1983
ESP (ms) 7.4 7.4 7.4 7.4
TEeff (ms) in SE-based TE (ms)
in GE-based
59.2 7.4 14.6 3.5 2.3 7.4 3.5 2.3
BW (MHz) 50 50 50 50 75 50 50 75
ETL 15 1 3 1
FA 90/180 90/180 180/90/180 60 10 90/180 90 10
NSA 3 3 1 4 1 3 5 1
TI (ms) 1700 1700 1700
Matrix 192x192x29 192x192x29 192x192x29 192x192x29 128x128x128 192x192x29 192x192x29 128x128x128
FOV (mm) 20x20x14.5 20x20x14.5 20x20x14.5 20x20x14.5 20x20x20 20x20x14.5 20x20x14.5 20x20x20
Mode 2D 2D 2D 2D 3D 2D 2D 3D
Scan time (min : sec) 4 : 12 4 : 48 9 : 36 4 : 28 4 : 14 4 : 48 4 : 24 4 : 14
https://doi.org/10.1371/journal.pone.0200611.t002
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approaches identified the highest CNR value at a TI of 1700 ms. A different outcome was
found when changing the TR parameter in addition to ETL (S1C3 and S1C4 Fig low Kendall’s
tau coefficient, -0.28). The in vivo CNR values dropped after the 9000 ms in contrast to the
simulation where the CNR continued to rise until reaching a maximum at a TR of 20000 ms.
The unexpected in vivo trend was thought to be related to the increasing number of ETL used
at longer TR than 9000 ms (ETL>3) causing inhomogeneity resulting in dephasing effects,
which in turn produced a signal dropping. The selected optimal MRI parameters were, there-
fore, chosen as 1700 ms TI and 9000 ms TR.
Gradient-echo based sequences
Gradient-echo based sequences results are presented in pre- and post-contrast conditions in
Fig 3 and S2 Fig. Although these graphs represent the case of a single mouse, they are a good
representation of the entire animal cohort. Mean CNR values were associated to a standard
deviation (SD) typically <10%. A coefficient of variation <10% was also found for the entire
cohort. Error bars are not included in the graphs. It has to be noted that the magnitude of the
computed and in vivo single CNR values differ significantly, primarily due to the complexity
in simulating the effect that the scanner hardware has on the acquisition and amplification of
the MRI signal. The analysis software for the in vivo data was an additional factor of magni-
tude values differences. Black arrows reported in Fig 3 and S2 Fig identified the optimal
parameters found for the in vivo and simulated approach. The TE was related to a bandwidth
of 50MH, as in spin-echo methods, which provided the highest CNR values between tissues
based on an in vivo test (data not shown).
A full view of the “optimal in vivo scanning parameters” gradient-echo base sequences is
reported in Table 2.
Gradient-echo (GRE). The GRE pre- and post-contrast in vivo data trend showed impor-
tant differences with the simulated counterpart when changing both FA (Fig 3A1,2 and 3B1,2) and
TR in addition to NSA without exceeding a 5-minute scan time limit (Fig 3A3,4 and 3B3,4). The
reasons behind such divergences are not entirely understood, although it can be speculated that
enhanced susceptibility effects experienced at high field played a major role. The GRE method is
indeed very sensitive to variations in T2 decaying which might have not been fully integrated in
the simulation. The optimal parameters were, therefore, chosen based on the highest CNR
achieved in the in vivo experiment as 60 degrees angle FA and 350 ms TR in pre-contrast condi-
tions, and 90 degrees angle and 275 ms TR in post-contrast conditions. The correlation between
in-vivo and simulated graphics patterns was also low, reporting low Kendall’s tau coefficient val-
ues (0.39 3A1 - 3A2; 0.20 3A3 - 3A4 and 0.22 S2C1 –S2C2; -0.20 S2C3 –S2C4)
Magnetization-prepared rapid gradient-echo (MP-RAGE). MP-RAGE reported a non-
matching CNR trend (low Kendall’s tau coefficient, -0.17) between the in vivo and simulated
data in pre-contrast conditions when testing the best TI parameter (S2B1,2 Fig). Such differ-
ences were also reflected in the failing of the scanning parameter comparison analysis. The rea-
sons behind such dissimilarities remain unclear. In all the remaining cases (S2B3,4, S2D1,2 and
S2D3,4 Fig) in vivo and simulation CNR seem to correlate well (high Kendall’s tau coefficient
0.80 B3 –B4; 0.67 D1 –D2; 1 D3 –D4) also identifying similar optimum scanning values. Opti-
mal parameters were set as 1700ms TI and 10 degrees FA for both pre- and post-contrast
conditions.
“Optimal in vivo scanning parameters”
The simulation technique wanted to achieve the “optimal in vivo scanning parameters” after a
validation process that compared the computed scanning parameters to those achieved in
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Fig 3. Gradient-echo based sequences diagrams. Gradient-echo (GRE) brain parenchyma-tumor mean CNR graphical representation during scanning parameters
optimization. Figs A1,3 and A2,4 report respectively in vivo and simulated CNR GRE data when changing FA and TR in addition to NSA (5-minute scan limit) in pre-
contrast conditions. Same approach is shown in Figs B1,3 and B2,4 in post-contrast conditions. Black arrows point at selected parameters that typically coincide with the
highest CNR providing the “optimal in vivo scanning parameters” in the in vivo approach and the “optimal computed scanning parameters” in the simulated approach.
The latter parameters are compared with the “Scanning parameters comparison analysis” and the outcome was reported as successful (YES) or failing (NO). Note that
although the graphs are related to a single mouse dataset, there is a good representation of the entire animal cohort.
https://doi.org/10.1371/journal.pone.0200611.g003
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vivo. Included is a list of those parameters that succeed and those that failed the scanning
parameter comparison analysis.
Successful comparison scanner parameter analysis:
Failed comparison scanner parameter analysis:
These latter parameters were re-inserted in the simulation and maintained constant at the
optimum in vivo experimental value.
The FOV and matrix parameters were not modified throughout the study, and it is believed
that their contribution does not affect the series of scanning parameters succeeding or failing
the compared analysis.
Example of “optimal in vivo scanning parameters” resulting images are reported in Fig 4.
These images and the related optimal parameters are representative of the entire cohort. This
was verified by running the in vivo and simulation approaches on all the animals ultimately
finding the same results which was also confirmed by coefficient of variation typically smaller
than 10% of the mean value, and the generally small variabilities between and within mice. In
other words, if any of the single animal CNR values were to be investigated, the “optimal in
vivo scanning parameters” outcome would have been identical to that shown herein.
Regarding the time spent running the in vivo compared to the simulated method, it was
found that the computed approach provided significant benefits with the exception of the GRE
method. The user performing the simulated method will have, in fact, to investigate exclusively
the “failed” scanning parameters by an in vivo test and acquire either a T1 or T2 or T2 map
depending on the sequence theoretical requirements. Conversely, a full sequential in vivo
approach involves acquiring a series of scans for each of the scanning parameters in addition
to a full data analysis. For instance in the case of spin-echo, it is estimated that, based on our
MRI methods and their acquisition timing, the simulated technique is at least twice as fast as
the conventional method in identifying the “optimal in vivo scanning parameters”.
Discussion
This study aimed to validate a numerical simulation based on MRI theory to an in vivo
approach in a glioblastoma murine model in order to provide “optimal in vivo scanning param-
eters”. Such parameters produce the highest CNR between healthy and tumor brain tissues
which typically translate to an increase in sensitivity and accuracy of the subsequent image
analysis. The computational approach simulated similar sequences to those used in an in vivo
experiment in an effort to reproduce the magnetization effects observed in a living mouse. The
SNR of healthy and tumor tissues collected with both in vivo and simulated approaches were
1) ETL, TR, NSA in the case of FSE T1 or T2 (pre- and post-contrast);
2) TI in the case of FLAIR T2 (pre-contrast);
3) FA, NSA in the case of MP-RAGE T1 (pre-contrast);
4) TI, FA, NSA in the case of MP-RAGE T1 (post-contrast);
https://doi.org/10.1371/journal.pone.0200611.t003
1) ESP in the case of FSE T1 or T2 (pre- and post-contrast);
2) TR in the case of FLAIR T2 (pre-contrast);
3) FA, TR, NSA in the case of GRE T1 (pre- and post-contrast);
4) TI in the case of MP-RAGE T1 (pre-contrast).
https://doi.org/10.1371/journal.pone.0200611.t004
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then analyzed through a CNR data analysis, and the respective scanning parameters were com-
pared. While it was found that the computational methods suffered several inaccuracies in
reproducing in vivo optimal parameters, these could be resolved in the majority of the cases
after adjusting some of the initial computed conditions. The latter conditions had to conform
to those achieved in the in vivo experiment and the limitations of a simulation approach to a
real in vivo situation were then highlighted.
The study focused on spin-echo (FSE and FLAIR) and gradient-echo (GRE and MP-RAGE)
based sequences. These methods are commonly used in clinical brain tumor studies and are
also relevant to pre-clinical murine brain tumor investigations. The limited inhomogeneity
experienced in the spin-echo based methods helped to create a better correlation between the
CNR computed and the in vivo values (Fig 2 and S1 Fig). On the other hand, the gradient-
echo based sequences being more susceptible to field inhomogeneity effects, produced diver-
gent CNR trends making the pursue of “optimal in vivo scanning parameters” a non-trivial task
Fig 4. Pre- and post-contrast images “optimal in vivo scanning parameters” of a glioblastoma murine model brain section. Figs A1, A2, A3 and A4 represent FSET2
FSET1, GRE and FLAIR pre-contrast images respectively. Tumor areas are well differentiated from the valuable brain parenchyma in FSET2. On FLAIR images,
excellent CSF signal saturation is achieved. Figs B1, B2, B3 and B4 represent FSET2 FSET1, GRE and MP-RAGE (the image contrast was inverted for visualization
purposes) post-contrast images respectively. Tumor areas are well differentiated from the healthy brain parenchyma in all scans. Contrast enhancement effects are
prominent in all T1 examinations.
https://doi.org/10.1371/journal.pone.0200611.g004
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(Fig 3 and S2 Fig). Specifically, the simulation of the standard GRE method revealed to be far
from accurate.
FSE was used as a T2- and T1-weighted sequence. As a T2-weighted method, it provided
excellent pre-contrast anatomical information and was able to well differentiate normal brain
from tumor areas that appeared hyperintense due to increased vascularization. This method is
commonly used post-contrast in multiple sclerosis studies, and thus was reported in this work.
Post-contrast T2-weighted sequence, however, do not provide any additional biological or tis-
sue structural information compared to a pre-contrast agent administration MRI acquisition.
As a T1-weighted method, the post-contrast in vivo data offer important information on the
tumor anatomy and permeability effects and therefore is a valuable investigating tool. Simula-
tion and in vivo data were highly correlated as shown by the Kendall’s tau coefficient so that
the computer program can be used as a reliable surrogate to the in vivo measurements in
order to obtain the MRI “optimal in vivo scanning parameters”. Of note that particular atten-
tion should be given to the ESP scanning parameter because chemical shift effects can repre-
sent a limiting factor in achieving well-correlated simulated to in vivo data.
FLAIR is a challenging method when followed by a refocusing flip angle train as studied by
Saranathan et al., due to issues related to CSF nulling point signal stability over time, the pri-
mary goal of such sequence [28]. Although not often used in pre-clinical studies, FLAIR is rou-
tinely used in the clinic making it an essential tool to apply in co-clinical projects. This study
shows that in vivo and simulation data well agreed in determining the best TI parameter while
having discrepancies in optimizing TR. Such differences could be related to the incrementing
number of excitation and refocusing flip angles in the absence of an optimization of the latter
refocusing angles. It has to be noted that the number of ETL used at the optimal in vivo TR of
9000 ms was 3 while increasing to 4 at 10000 ms TR. Such increment could lead to variability
in signal-to-noise in the acquired images reflecting a drop of CNR between tissues. This
method, similarly to the FSET2, is also not commonly used in the post-contrast setting.
Despite being a gradient-echo based method, the 3D MP-RAGE generally reported well-
correlated CNR values with high Kendall’s tau coefficient between in vivo and simulated
approaches. Given that this sequence is most commonly utilized after, rather than prior to contrast
agent administration, the simulation can be reliably used to define the “optimal in vivo scanning
parameters” in post-contrast conditions. Differences between the pre- and post-contrast behavior
in identifying the optimal TI value, must lay in a reduction in inhomogeneity effects, which follow
decremented T1 values, but also in a better characterization of the tissues. The rather complex
equation, presented in the “Theory” section, which simulates the MP-RAGE sequence, is therefore
offering a good representation of the acquired in vivo signal-to-noise. Of note, contrary to the
many parameters which dynamically varied in the simulation, TD was maintained to a “0” value
primarily because of a previous publication [22] reporting an enhanced efficacy at such range
which was also verified in our laboratory in a separate in vivo experiment (data not reported).
The simulation computer program remains an important tool in MRI parameters optimiza-
tion and the different C++ codes used in this study are hereby provided and can be freely used
(S1, S2, S3, S4 and S5 Files). When engaging such simulations, the user can select and vary the
range of several parameters in a dynamic manner in order to automatically achieve the “opti-
mal scanning computed parameters” and consequently the “optimal in vivo scanning parame-
ters”. As we have seen, however, the computed outcomes do not always accurately represent
the in vivo relationship between tissue contrasts. To pursue a simulation which better adheres
to in vivo conditions, some of the simulated parameters can no longer change dynamically
during the simulation, but must be maintained constant to those found in vivo. Such incoher-
ence between the in vivo and simulation approaches, confirm the latter to be a simplistic
method. A numerical calculation does not always take into account in vivo aspects such as
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field inhomogeneity, hardware limitations and biological effects in addition to artifacts arising
from magnetic susceptibility gradients or chemical shift effects that become more pronounced
at high static fields [29], thus resulting in misleading interpretations.
Nevertheless, this study proposes some guidelines on how to validate a simulation against
an in vivo scenario in order to achieve “optimal in vivo scanning parameters”, and highlights
the parameters that have to be re-introduced into the numerical simulation after CNR com-
parison analysis. Our approach is in contrast with the more traditional MRI simulations where
a stand-alone computing program uses an analytical approach and theoretical approximation
to predict the rather complex magnetization processes of the body under investigation [30–
32]. Most of these simulations design elegant, but still job-selective, numerical corrections to
overcome either specific hardware limitations, such as RF and magnetic field imperfections,
non-linear gradients and gradients field modulation, or image artifacts such as chemical shift,
spin dephasing and susceptibility-induced off-resonance. These approaches are generally
developed for a clinical environment and/or educational purposes. In contrast, our work, did
not aim at resolving specific problematic issues related to signal acquisition, image processing
or hardware limitations, but rather to use information gained from in vivo experiments and
apply it to some specific scanning parameters to correct the discrepancies seen between the
computed and a in vivo scenario, and to forestall the best scanning parameters to use to best
differentiate one tissue from the next.
Our proposed simulated approach can be utilized to further improve the accuracy and opti-
mization of scanning parameters by decreasing the range of variation of each variable. For
instance, in our spin-echo cases, the TR parameter was varied following an increment of
1000ms, but having proved that such parameter is fully compliant to the simulation, the range
of variation could be drastically reduced (100ms for example) and a more accurate value was
found from the simulation alone. If the same situation were to be repeated in vivo, the process
would consume a considerable amount of time. Higher accuracy of “optimal scanning in vivo
parameters” will result in further maximized CNRs, and better delineation, differentiation and
characterization of the diseased model under study.
The simulation technique reported here is not limited to the glioblastoma murine model
but can be used for any type of cancer or tissue. Of note, complex tissue structures, such as
necrosis or large edematous regions within a tumor mass, can affect significant areas of the tis-
sue under study, and the T1, T2 or T2 can also significantly vary within the tissue itself. In
these cases, the user will have to explore more sophisticated mathematical approaches, rather
than an average between relaxation times, to achieve spatial/relaxation “weighted” values in
order to reflect the tissue properties, and identify one relaxation time value to use in the simu-
lation. Alternatively, one could test the simulation technique on phantoms with various relaxa-
tion times properties before approaching the in vivo experiment. We tested the simulation
using a water/oil phantom that provided similar successful and failed scanning parameters to
those presented in this work (results not shown). We hope that our proposed methodology
can help harmonize the choice of scanning parameters across different scanners, and help vali-
date the use of MRI as an effective tool for translational studies in cancer and other diseases.
In conclusion, this study presented a proposed computer simulation approach for MRI in
vivo scanning parameter optimization in a glioblastoma murine model as a validated surrogate
for the more time consuming in vivo approach. The programming used to develop this simula-
tion technique relied on a theoretical model and on information provided by the concomitant
in vivo study to introduce corrections to the initial simulated conditions as to generate a reli-
able computed approach and validate the simulation approach against the in vivo acquisition.
This proposed method could potentially be extended across pre-clinical and clinical scanners
and to other disease models.
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Supporting information
S1 File. C++ program file for fast spin-echo. The T1 and T2 values and scanning parameters
can be edited within the program file to define pre- and post-contrast conditions.
(CPP)
S2 File. C++ program file for FLAIR. The T1 and T2 values and scanning parameters can be
edited within the program file to define pre- and post-contrast conditions.
(CPP)
S3 File. C++ program fils for gradient-echo. The T1 and T2 and scanning parameters can
be edited within the program file to define pre- and post-contrast conditions.
(CPP)
S4 File. C++ program file for MPRAGE. The T1 and T2 values and scanning parameters can
be edited within the program file to define pre- and post-contrast conditions.
(CPP)
S5 File. C++ program file for fast spin-echo with changeable T1 and T2. The T1 T2 and T2
values and scanning parameters can be edited within the program file to define pre- and post-
contrast conditions.
(CPP)
S1 Table. T1 T2 and T2 variability values for brain parenchyma, CSF and tumor tissues in
a glioblastoma murine model for pre-contrast and post-contrast conditions (30 minutes
after contrast agent IP injection).
(TIFF)
S1 Fig. Spin-echo based sequences CNR data. Fast-spin-echo T2- (FSET2) and T1-weighted
(FSET1) brain parenchyma-tumor and Fluid Attenuated Inversion Recovery (FLAIR) brain
parenchyma-CSF mean CNR graphical representation. In pre-contrast conditions: Figs A1,3,5
and A2,4,6 report in vivo and simulated CNR FSET2 data, respectively, when changing ESP,
ETL, TR and NSA (the scan time was limited to 5 minutes). Figs B1,3,5 and B2,4,6 report in vivo
and simulated CNR FSET1 data, respectively, when changing ESP, ETL, TR and NSA (the
scan time was limited to 5 minutes). Figs C1,3 and C2,4 show in vivo and simulated CNR
FLAIR data, respectively, when changing TI, TR and ETL. In this latter case the scan time was
limited to 10 minutes. In post-contrast conditions: Figs D1,3 and D2,4 reported in vivo and sim-
ulated CNR FSET1 data, respectively, when changing ESP, TR and NSA (the scan time was
limited to 5 minutes). Black arrows point at selected parameters that typically coincide with
the highest CNR providing with the “optimal in vivo scanning parameters” in the in vivo
approach and the “optimal computed scanning parameters” in the simulated approach.
(TIFF)
S2 Fig. Gradient-echo based sequences diagrams. Gradient-echo (GRE) and Magnetization-
Prepared Rapid Gradient-Echo (MP-RAGE) brain parenchyma-tumor mean CNR graphical
representation during scanning parameters optimization. Figs A1,3 and A2,4 report in vivo and
simulated reports in vivo CNR GRE data, respectively, when changing FA and TR in addition
to NSA (5-minute scan limit) in pre-contrast conditions. Same approach is shown in Figs C1,3
and C2,4 in post-contrast conditions. Figs B1,3 and B2,4 report in vivo and simulated CNR
MP-RAGE data, respectively, when changing TI and FA (5-minute scan limit) in pre-contrast
conditions. Same approach is shown in Figs D1,3 and D2,4 in post-contrast conditions. Black
arrows point at selected parameters that typically coincide with the highest CNR providing
with the “optimal in vivo scanning parameters” in the in vivo approach and the “optimal
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computed scanning parameters” in the simulated approach.
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